SLAS Discovery

Papers
(The median citation count of SLAS Discovery is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay120
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models47
Bioassay protocol metadata annotation: Proposed standards adoption44
Ex vivo discovery of synergistic drug combinations for hematologic malignancies41
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei40
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery34
Protocol for 3D screening of lung cancer spheroids using natural products31
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection29
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature27
Outline and background for the EU-OS solubility prediction challenge26
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening24
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies23
Emerging drug discovery ecosystems22
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling22
Role Of Vaccines Against COVID-19 Pandemic21
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin19
Drug repurposing screen for the rare disease ataxia-telangiectasia18
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells17
Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease16
An efficient and scalable data analysis solution for automated electrophysiology platforms16
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules16
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice14
The Impact of Assay Design on Medicinal Chemistry: Case Studies14
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer14
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components14
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis13
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines13
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicals12
Screening for molecular glues – Challenges and opportunities12
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening12
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors12
In Memoriam12
Screening for modulators of autism spectrum disorder using induced human neurons11
High-throughput screening for identifying acetylcholinesterase inhibitors: Insights on novel inhibitors and the use of liver microsomes11
Protocol to develop A 3D tumor model for drug testing applications11
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells11
High-Throughput cell-based immunofluorescence assays against influenza10
Bonferroni’s method, not Tukey’s, should be used to control the total number of false positives when making multiple pairwise comparisons in experiments with few replicates10
Development of a live cell assay for the zinc transporter ZnT810
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library9
A perspective on the discovery of enzyme activators9
Automated high-throughput, high-content 3D imaging of intact pancreatic islets9
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]9
Deep Learning Image Analysis of High-Throughput Toxicology Assay Images9
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies9
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.8
A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies8
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons8
VOC analysis for rapid, early detection of bacteria, mold, and mycoplasma in cell and tissue cultures8
Identification of potent small molecule inhibitors of SARS-CoV-2 entry8
Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine8
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch8
Publisher's Note8
Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines7
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant7
SLAS Discovery – The Next Generation of Research7
A robust CETSA data analysis automation workflow for routine screening7
Phenotypic Screening Following Transcriptomic Deconvolution to Identify Transcription Factors Mediating Axon Growth Induced by a Kinase Inhibitor7
Creating a more strategic small molecule biophysical hit characterization workflow7
Using chemical and biological data to predict drug toxicity7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols7
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc7
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models7
Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes7
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance6
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems6
Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology6
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase6
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models6
Identification of novel inflammasome inhibitors via cellular NLRP3 target engagement assays6
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma6
A biochemical screening platform to target chromatin states using condensates as a tool5
Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health Assay Guidance Man5
Protocols in drug discovery5
Characterisation of high throughput screening outputs for small molecule degrader discovery5
Robustness of NanoBiT luciferase complementation technology in the presence of widely used kinase inhibitors5
WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin5
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening5
MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling5
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids5
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens5
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay5
Development of a continuous assay for high throughput screening to identify inhibitors of the purine salvage pathway in Plasmodium falciparum5
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction4
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-24
Antimicrobial resistance: Linking molecular mechanisms to public health impact4
Thank You to Our 2021 Reviewers4
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors4
High-throughput approaches to uncover synergistic drug combinations in leukemia4
Drug discovery efforts at George Mason University4
Corelet™ platform: Precision high throughput screening for targeted drug discovery of biomolecular condensates4
Development of a live cell assay for real-time monitoring the interactions between the Hippo pathway components 14-3-3 and TAZ4
DeepTI: A deep learning-based framework decoding tumor-immune interactions for precision immunotherapy in oncology4
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors4
Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase4
The SLAS Discovery Editor's Top 10 for 20214
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling4
Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives4
Addressing Unusual Assay Variability with Robust Statistics4
Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells4
A phenotypic screen for compounds that reverse cAMP-mediated suppression of T cell functions4
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS4
Discovery and validation of small molecule stabilizers of mutant triose phosphate isomerase (TPI) as potential lead candidates for TPI deficiency4
Compound management in a virtual research organization: The cornerstone of a reliable MMV discovery engine4
Deep phenotyping of surface stimulatory and inhibitory co-receptors on cancer-resident T and NK cells reveals cell subsets within the tumor-reactive CTL population that are uniquely defined by NKG2A e3
Epithelial 3D-spheroids as a tool to study air pollutant-induced lung pathology3
Point-of-use, automated fabrication of a 3D human liver model supplemented with human adipose microvessels3
Lead identification using 3D models of pancreatic cancer3
Graph neural networks for the identification of novel inhibitors of a small RNA3
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library3
Automated quality control tool for high-content imaging data by building 2D prediction intervals on reference biosignatures3
Advancing the development of TRIP13 inhibitors: A high-throughput screening approach3
Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay3
Mathematical relationships between control group variability and assay quality metrics3
Treating Cells as Reagents to Design Reproducible Assays3
Orthogonal temperature-related intensity change (TRIC) and TR-FRET as a high-throughput screening platform for the discovery of SLIT2 binders: A proof-of-concept approach3
Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection3
Alternate dyes for image-based profiling assays3
Grouping concentration response curves by features of their shape to aid rapid and consistent analysis of large data sets in high throughput screens3
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA13
A multi-parametric high throughput assay for detecting beta-cell proliferation in dispersed primary islets3
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors3
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors3
High throughput screening for compounds to the orphan nuclear receptor NR2F63
Fragment-based screening: A new paradigm for ligand and target discovery3
Development of a BRET based chloride biosensor for high throughput screening of KCC2 modulators3
Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction3
Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay3
A high throughput assay for phosphoribosylformylglycinamidine synthase3
Optimising cell-based bioassays via integrated design of experiments (ixDoE) - A practical guide3
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library3
High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy3
The role of m6A in lipid metabolism-related diseases3
A mechanism of action-reflective, dual cell-based bioassay for determining the bioactivity of sclerostin-neutralizing antibodies2
Identification of chemicals breaking the USP8 interaction with its endocytic substrate CHMP1B2
Magnetic three-dimensional bioprinting protocol for salivary gland mucoepidermoid carcinoma tumoroid culture2
Structure-activity relationships of thiadiazole agonists of the human secretin receptor2
A “Failed” Assay Development for the Discovery of Rescuing Small Molecules from the Radiation Damage2
High-throughput method to analyze the cytotoxicity of CAR-T Cells in a 3D tumor spheroid model using image cytometry2
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins2
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids2
BRET measurement on CCD camera-based microtiter plate readers2
MT1G activation in dopaminergic neurons identifies chelators and their relationships to cytotoxicity2
Micro/nano topological modification of TiO2 nanotubes activates Thy-1 signaling to control osteogenic differentiation of stem cells2
Corrigendum to “Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology” [SLAS Discovery, Volume 27 (2022) P140-147/2472-5552]2
1st EU-OPENSCREEN/SLAS data mining competition to predict compounds solubility2
WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines2
Toxicity evaluation of pharmaceutical drugs and quantum dots (QDs) using zebrafish embryos – A comprehensive review2
Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer2
Development of a biotin–streptavidin-enhanced enzyme-linked immunosorbent assay (BA-ELISA) for high-throughput screening of KRASG12C inhibitors2
High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle2
HTS discovery of PARP1-HPF1 complex inhibitors in cancer2
The openOCHEM consensus model is the best-performing open-source predictive model in the First EUOS/SLAS joint compound solubility challenge2
ATPase activity profiling of three human DExD/H-box RNA helicases2
0.04718017578125